Literature DB >> 19149638

Neuronal regulators and vascular dysfunction in Raynaud's phenomenon and systemic sclerosis.

Carmen Fonseca1, David Abraham, Markella Ponticos.   

Abstract

Raynaud's phenomenon (RP) results from an exaggerated cutaneous vasospastic response to cold or emotional stress. The mechanisms that lead to impaired cutaneous vascular tone are complex. The regulation of cutaneous vasoconstriction and vasodilation, involves altered sympathetic nerve activity and a host of neuronal regulators, including adrenergic and non-adrenergic, as well as REDOX signalling and other signalling such as the RhoA/ROCK pathway. This review summarises the literature concerning the regulation of vascular tone by neurohumoral factors that may be involved in RP and systemic sclerosis (SSc).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19149638     DOI: 10.2174/157016109787354105

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  9 in total

1.  Mean platelet volume seems to be a valuable marker in patients with systemic sclerosis.

Authors:  Serdar Soydinc; Ibrahim Halil Turkbeyler; Yavuz Pehlivan; Gulcimen Soylu; Mehmet Fatih Goktepe; Muhammed Bilici; Orhan Zengin; Bunyamin Kisacik; Ahmet Mesut Onat
Journal:  Inflammation       Date:  2014-02       Impact factor: 4.092

2.  Mapping the extracellular and membrane proteome associated with the vasculature and the stroma in the embryo.

Authors:  Fabienne Soulet; Witold W Kilarski; Florence Roux-Dalvai; John M J Herbert; Izabela Sacewicz; Emmanuelle Mouton-Barbosa; Roy Bicknell; Patricia Lalor; Bernard Monsarrat; Andreas Bikfalvi
Journal:  Mol Cell Proteomics       Date:  2013-05-14       Impact factor: 5.911

3.  Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis.

Authors:  Theodoros Dimitroulas; Georgios Giannakoulas; Klio Papadopoulou; Tilemahos Sfetsios; Haralambos Karvounis; Hariklia Dimitroula; Despina Parcharidou; Georgios Koliakos; Alexandros Garyfallos; Ioannis Styliadis; Loukas Settas
Journal:  Clin Rheumatol       Date:  2010-06-05       Impact factor: 2.980

4.  In vivo roles for myosin phosphatase targeting subunit-1 phosphorylation sites T694 and T852 in bladder smooth muscle contraction.

Authors:  Cai-Ping Chen; Xin Chen; Yan-Ning Qiao; Pei Wang; Wei-Qi He; Cheng-Hai Zhang; Wei Zhao; Yun-Qian Gao; Chen Chen; Tao Tao; Jie Sun; Ye Wang; Ning Gao; Kristine E Kamm; James T Stull; Min-Sheng Zhu
Journal:  J Physiol       Date:  2014-12-23       Impact factor: 5.182

5.  Peripheral neuropathy: a complication of systemic sclerosis.

Authors:  Tracy M Frech; Gordon Smith; Melissa Reily; James Chamberlain; Maureen A Murtaugh; Jason Penrod; Michael J Battistone; Barry M Stults
Journal:  Clin Rheumatol       Date:  2013-02-13       Impact factor: 2.980

6.  Vascular involvement in systemic sclerosis (scleroderma).

Authors:  Debendra Pattanaik; Monica Brown; Arnold E Postlethwaite
Journal:  J Inflamm Res       Date:  2011-07-26

7.  Juvenile localized scleroderma with port wine stain: coincidental or possible common pathogenetic association.

Authors:  Seval Dogruk Kacar; Pinar Ozuguz; Serap Polat; Emre Kacar; Onur Polat; Cigdem Tokyol
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

8.  Impairment of microcirculation and vascular responsiveness in adolescents with primary Raynaud phenomenon.

Authors:  Bernadett Mosdósi; Kata Bölcskei; Zsuzsanna Helyes
Journal:  Pediatr Rheumatol Online J       Date:  2018-03-23       Impact factor: 3.054

9.  Gut disease in systemic sclerosis - new approaches to common problems.

Authors:  Jessica Zhu; Tracy Frech
Journal:  Curr Treatm Opt Rheumatol       Date:  2019-02-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.